Burjeel Holdings to Revolutionize Cancer Care in MENA with 90% Cheaper CAR-T Therapy

In a groundbreaking move set to transform cancer treatment access across MENA, Burjeel Holdings has partnered with U.S.-based non-profit Caring Cross to locally manufacture CAR-T cell therapies at up to 90% less than current international…
Read More...